Mark Koba is a senior editor at CNBC.com. Topics for his feature story writing include the business of politics, health care, employment and the economy.
Before working at CNBC.com, he spent 11 years at Bloomberg LP, where among various duties, he was program producer for the award-winning "Bloomberg Small Business" television show.
Koba's background includes a decade of news writing and show producing at CNN, E! Entertainment Television, ABC's "World News Now," "Good Morning America" and CBS' "This Morning."
Follow Mark Koba on Twitter @MarkKobaCNBC.
The beverage sector is fairing well of late with news of acquisitions and executive promotions within the major players. The Dow Jones beverage index has gained 3% this week and more than 12% year to date. And Coca-Cola and Pepsi are up 5% and 2% respectively. So--will this "long drink" of market success continue to last?
HCA and Kinder Morgan. Just a couple of recent management led buyouts. But with that list growing--the issues of whether a ceo or management team is acting in the best interests of shareholders has become more pressing. In fact--it's prompting one shareholder with some unique insights to speak out exclusively to CNBC.
It's been a week since Microsoft released it's Vista operating system to businesses--and one security analyst says the system is not safe and actually vulnerable to some major viruses. Ron O'Brien is Senior Security Analyst at Sophos. He appeared on "Squawk Box."
Good morning. We'll start with our quote of the day from journalist Barry C. Forbes: "Don't forget until too late that the business of life is not business but living." Something to remember for those working 10 hour days. Now--here's what's ahead for the day on cnbc.com and CNBC-TV.
There's late word from CNBC's Mike Huckman. He reported in "Closing Bell' that the FDA stent conference came out in support of drug-coated stents. There had been concerns the drug-coated stents caused blood clots--and the metal stents did not. But the FDA says the proof is inconclusive.
It looks like the California State Attorney General's office is getting ready to settle with Hewlett-Packard--over civil charges related to the corporate spying scandal. That scandal led to the resignation of HP Chairman Patricia Dunn. Don Clark is the San Francisco Bureau Chief of The Wall Street Journal.
The markets are more than likely gearing up for the most anticipated piece of economic data this week--that's the U.S. jobs report for November. It comes out Friday. CNBC's Steve Liesman gave a preview on "Power Lunch." Steve said the Dow Jones Survey of Economists sees job growth of 110,000 for November.
The U.S. Federal Drug Administration is right now weighing in on the heated debate over drug coated stents versus metal ones. Stents are implanted in patients to stop heart attacks. They're looking into evidence that drug-coated stents-- may lead to dangerous blood clots. It's a huge concern that's effecting millions of heart patients. It's also effecting the $5 billion dollar drug-coated stent industry.
In a "First on CNBC-TV" Eli Lilly CEO and Chairman Sidney Taurel sat down with Mike Huckman on "Squawk Box" to talk about the company--as it meets with analysts today and issued new guidance. The pharmaceutical company says sales growth for 2007 will be in the low end of the 7-9% range--versus 6% for 2006.